메뉴 건너뛰기




Volumn 23, Issue 1, 2014, Pages 1-4

Don't middle your MIDs: Regression to the mean shrinks estimates of minimally important differences

Author keywords

Clinical significance; Minimally important difference; Patient reported outcomes; Quality of life; Regression to the mean

Indexed keywords

ARTICLE; HUMAN; INFORMATION PROCESSING; MEDICAL RESEARCH; METHODOLOGY; OUTCOME ASSESSMENT; PHYSIOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL BIAS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84893276569     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-013-0443-4     Document Type: Article
Times cited : (68)

References (15)
  • 1
    • 0024852022 scopus 로고
    • Measurement of health status. Ascertaining the minimal clinically important difference
    • DOI 10.1016/0197-2456(89)90005-6
    • Jaeschke, R., Singer, J., & Guyatt, G. H. (1989). Measurement of health status: ascertaining the minimal clinically important difference. Controlled Clinical Trials, 10, 407-415. (Pubitemid 20025670)
    • (1989) Controlled Clinical Trials , vol.10 , Issue.4 , pp. 407-415
    • Jaeschke, R.1    Singer, J.2    Guyatt, G.H.3
  • 2
    • 33644939735 scopus 로고    scopus 로고
    • Patient-reported outcome measures: Use in medical product development to support labeling claims
    • US Food and Drug Administration Accessed March 20, 2013
    • US Food and Drug Administration. (2009). Patient-reported outcome measures: Use in medical product development to support labeling claims. Guidance for industry. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM071975.pdf. Accessed March 20, 2013.
    • (2009) Guidance for Industry
  • 4
    • 77955099042 scopus 로고    scopus 로고
    • Minimal important differences and response shift in health-related quality of life; A longitudinal study in patients with multiple myeloma
    • 2922103 20678240 10.1186/1477-7525-8-79
    • Kvam, A. K., Wisløff, F., & Fayers, P. M. (2010). Minimal important differences and response shift in health-related quality of life; A longitudinal study in patients with multiple myeloma. Health and Quality of Life Outcomes, 8, 79.
    • (2010) Health and Quality of Life Outcomes , vol.8 , pp. 79
    • Kvam, A.K.1    Wisløff, F.2    Fayers, P.M.3
  • 6
    • 0038558113 scopus 로고    scopus 로고
    • Hi! How are you? Response shift, implicit theories and differing epistemologies
    • DOI 10.1023/A:1023211129926
    • Norman, G. (2003). Hi! How are you? Response shift, implicit theories and differing epistemologies. Quality of Life Research, 12, 239-249. (Pubitemid 36549532)
    • (2003) Quality of Life Research , vol.12 , Issue.3 , pp. 239-249
    • Norman, G.1
  • 7
    • 20144382504 scopus 로고    scopus 로고
    • Approaches and recommendations for estimating minimally important differences for health-related quality of life measures
    • DOI 10.1081/COPD-200050663
    • Hays, R. D., Farivar, S. S., & Liu, H. (2005). Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. Journal of Chronic Obstructive Pulmonary Disease, 2, 63-67. (Pubitemid 40776225)
    • (2005) COPD: Journal of Chronic Obstructive Pulmonary Disease , vol.2 , Issue.1 , pp. 63-67
    • Hays, R.D.1    Farivar, S.S.2    Liu, H.3
  • 8
    • 37549004786 scopus 로고    scopus 로고
    • Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
    • 18177782 10.1016/j.jclinepi.2007.03.012
    • Revicki, D., Hays, R. D., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of Clinical Epidemiology, 61, 102-109.
    • (2008) Journal of Clinical Epidemiology , vol.61 , pp. 102-109
    • Revicki, D.1    Hays, R.D.2    Cella, D.3    Sloan, J.4
  • 10
    • 68349113753 scopus 로고    scopus 로고
    • Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: Validation studies from two phase 3 clinical trials
    • 10.1167/iovs.08-3225
    • Suňer, I. J., Kokame, G. T., Yu, E., Ward, J., Dolan, C., & Bressler, N. M. (2009). Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: Validation studies from two phase 3 clinical trials. Investigative Ophthalmology & Visual Science, 50, 3629-3635.
    • (2009) Investigative Ophthalmology & Visual Science , vol.50 , pp. 3629-3635
    • Suňer, I.J.1    Kokame, G.T.2    Yu, E.3    Ward, J.4    Dolan, C.5    Bressler, N.M.6
  • 11
    • 84893311728 scopus 로고    scopus 로고
    • Linking should replace regression when mapping from profile to preference-based measures
    • submitted
    • Fayers, P. M., & Hays, R. D. (2013). Linking should replace regression when mapping from profile to preference-based measures. Value in Health (submitted).
    • (2013) Value in Health
    • Fayers, P.M.1    Hays, R.D.2
  • 13
    • 34447118323 scopus 로고    scopus 로고
    • Linking scores from multiple health outcome instruments
    • DOI 10.1007/s11136-006-9155-3
    • Dorans, N. J. (2007). Linking scores from multiple health outcome instruments. Quality of Life Research, 16(Suppl 1), 85-94. (Pubitemid 47036911)
    • (2007) Quality of Life Research , vol.16 , Issue.SUPPL. 1 , pp. 85-94
    • Dorans, N.J.1
  • 14
    • 0037980149 scopus 로고    scopus 로고
    • Interpretation of changes in health-related quality of life: The remarkable universality of a half a standard deviation
    • 12719681
    • Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of a half a standard deviation. Medical Care, 41, 582-592.
    • (2003) Medical Care , vol.41 , pp. 582-592
    • Norman, G.R.1    Sloan, J.A.2    Wyrwich, K.W.3
  • 15
    • 5444246327 scopus 로고    scopus 로고
    • Half standard deviation estimate of the minimally important difference in HRQOL scores?
    • DOI 10.1586/14737167.4.5.515
    • Farivar, S. S., Liu, H., & Hays, R. D. (2004). Half standard deviation estimate of the minimally important difference in HRQOL scores? Expert Review of Pharmacoeconomics and Outcomes Research, 4, 515-523. (Pubitemid 39359638)
    • (2004) Expert Review of Pharmacoeconomics and Outcomes Research , vol.4 , Issue.5 , pp. 515-523
    • Farivar, S.S.1    Liu, H.2    Hays, R.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.